The Role of Scavenger Receptor Class B Type 1 in Humans
B 型清道夫受体 1 在人类中的作用
基本信息
- 批准号:7983748
- 负责人:
- 金额:$ 80.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2014-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcylationAdrenal GlandsAffectAfrican AmericanAllelesAsiansAtherosclerosisBiological AssayBloodBlood specimenBody mass indexCardiovascular DiseasesCardiovascular systemCaucasiansCaucasoid RaceCell membraneCellsChemicalsCholesterolCholesterol EstersCodeDNADataDockingEndothelial CellsEventFemaleGenesGeneticGenetic PolymorphismGenetic TranscriptionGenetic VariationGenomicsGenotypeGoalsHaplotypesHeart DiseasesHepatocyteHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHispanicsHumanHydroxyl RadicalIn VitroInfertilityKnockout MiceLipidsLipoprotein ReceptorLipoproteinsMeasurementMeasuresMediatingMessenger RNAMinorMusMyocardial InfarctionOutcomeOvaryParticipantParticle SizePersonsPlasmaPlasmidsPopulationPrimer ExtensionProtein DeficiencyProteinsRNARadiolabeledRecruitment ActivityRegression AnalysisResearch Project GrantsRiskRoleSR-B proteinsSR-BI receptorSample SizeSamplingShapesSpecific qualifier valueStructureTestingTestisTissuesTranslationsVariantVery low density lipoproteinWestern Blottingbasecardiovascular disorder riskcohortgenetic associationhigh density lipoprotein receptorinflammatory markerinsightinterestmacrophagemacrophage scavenger receptorsmonocyteprematurepromoterprotein expressionpublic health relevanceradiotracerreceptor expressionresearch studytranslation assayuptake
项目摘要
DESCRIPTION (provided by applicant): High density lipoprotein cholesterol (HDL-C) levels are thought to protect against cardiovascular disease. This may or may not be true in certain populations. The long-term goal of this research project is to determine if a deficiency in the lipoprotein receptor, scavenger receptor class B type I or SR-BI, is a cause of high levels of HDL-C and, perhaps paradoxically, an increased risk for cardiovascular disease. In specific aim 1, we will perform in vitro experiments to examine the mechanism(s) by which certain SR-BI gene (SCARB1) variants affect SR-BI protein expression. In specific aim 2, we will continue recruiting subjects with HDL-C levels above 60 mg/dl (this is because levels above 60 mg/dl are thought to be cardioprotective) and obtaining blood specimens to measure cholesterol levels, DNA, and monocyte-derived macrophage that express SR-BI protein. We will examine the association of genetic variations within the SCARB1 gene with lipid levels, macrophage SR-BI protein and RNA expression and SR-BI function (as measured by the uptake of cholesteryl esters from radiolabeled HDL). We will also examine the association of SCARB1 polymorphisms and lipid levels and subclinical atherosclerosis in participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and in subjects with premature myocardial infarction (Myocardial Infarction Genetics Consortium Study). The results from our studies will provide further insight into the role of SR-BI on lipid levels and cardiovascular disease in subjects with elevated levels of HDL-C, in a larger population (MESA) well-represented by persons of Caucasian, African-American, Hispanic and Asian ancestry, and in subjects with premature myocardial infarction.
PUBLIC HEALTH RELEVANCE: High density lipoproteins (HDL) are considered the "healthy" or "good" fraction of the blood cholesterol levels. However, heart disease can occur despite a person having desirable levels of HDL. Our study will examine whether variations in the gene for the HDL receptor, scavenger receptor class B type I or SR-BI, might be associated with good levels of HDL and heart disease.
描述(由申请人提供):高密度脂蛋白胆固醇(HDL-C)水平被认为可以预防心血管疾病。对于某些人群来说,这可能是真的,也可能不是。该研究项目的长期目标是确定脂蛋白受体(B 型清道夫受体 I 型或 SR-BI)的缺陷是否是导致高 HDL-C 水平的原因,并且可能是矛盾的是,导致心血管疾病风险增加。在具体目标 1 中,我们将进行体外实验来检查某些 SR-BI 基因 (SCARB1) 变体影响 SR-BI 蛋白表达的机制。在具体目标 2 中,我们将继续招募 HDL-C 水平高于 60 mg/dl 的受试者(这是因为水平高于 60 mg/dl 被认为具有心脏保护作用),并获取血液样本来测量胆固醇水平、DNA 和表达 SR-BI 蛋白的单核细胞来源的巨噬细胞。我们将检查 SCARB1 基因内的遗传变异与脂质水平、巨噬细胞 SR-BI 蛋白和 RNA 表达以及 SR-BI 功能(通过从放射性标记的 HDL 中摄取胆固醇酯来测量)的关联。我们还将检查动脉粥样硬化多种族研究 (MESA) 参与者和早发性心肌梗死受试者(心肌梗死遗传学联盟研究)的 SCARB1 多态性与血脂水平和亚临床动脉粥样硬化的关联。我们的研究结果将进一步深入了解 SR-BI 对 HDL-C 水平升高的受试者、以白种人、非裔美国人、西班牙裔和亚洲血统的人为代表的较大人群 (MESA) 以及早发心肌梗死受试者的血脂水平和心血管疾病的作用。
公共健康相关性:高密度脂蛋白 (HDL) 被认为是血液胆固醇水平的“健康”或“良好”部分。然而,尽管一个人的高密度脂蛋白水平达到理想水平,心脏病还是可能发生。我们的研究将检验 HDL 受体、B 类清道夫受体 I 型或 SR-BI 基因的变异是否可能与高 HDL 水平和心脏病相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Annabelle Rodriguez其他文献
Annabelle Rodriguez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Annabelle Rodriguez', 18)}}的其他基金
THE ROLE OF THE HDL RECEPTOR, SCAVENGER RECEPTOR CLASS B TYPE I, IN HUMAN
HDL 受体(B 类清道夫受体 I 型)在人体中的作用
- 批准号:
7607491 - 财政年份:2006
- 资助金额:
$ 80.79万 - 项目类别:
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN SUBJECTS WITH TYPE
罗格列酮在调节 HDL 胆固醇的作用
- 批准号:
7607475 - 财政年份:2006
- 资助金额:
$ 80.79万 - 项目类别:
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS
人类 HDL 受体 SR-BI 缺乏
- 批准号:
7607476 - 财政年份:2006
- 资助金额:
$ 80.79万 - 项目类别:
THE ROLE OF ROSIGLITAZONE IN MODULATING HDL CHOLESTEROL IN TYPE 2 DIABETES
罗格列酮在 2 型糖尿病中调节 HDL 胆固醇的作用
- 批准号:
7375834 - 财政年份:2005
- 资助金额:
$ 80.79万 - 项目类别:
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS
人类 HDL 受体 SR-BI 缺乏
- 批准号:
7375835 - 财政年份:2005
- 资助金额:
$ 80.79万 - 项目类别:
DEFICIENCY OF THE HDL RECEPTOR, SR-BI, IN HUMANS
人类 HDL 受体 SR-BI 缺乏
- 批准号:
7204470 - 财政年份:2004
- 资助金额:
$ 80.79万 - 项目类别:
Deficiency of the HDL receptor, SR-BI, in humans
人类 HDL 受体 SR-BI 缺乏
- 批准号:
6872990 - 财政年份:2004
- 资助金额:
$ 80.79万 - 项目类别:
The Role of Scavenger Receptor Class B Type 1 in Humans
B 型清道夫受体 1 在人类中的作用
- 批准号:
8475494 - 财政年份:2004
- 资助金额:
$ 80.79万 - 项目类别:
Deficiency of the HDL receptor, SR-BI, in humans
人类 HDL 受体 SR-BI 缺乏
- 批准号:
7050146 - 财政年份:2004
- 资助金额:
$ 80.79万 - 项目类别:
The Role of Scavenger Receptor Class B Type 1 in Humans
B 型清道夫受体 1 在人类中的作用
- 批准号:
8277901 - 财政年份:2004
- 资助金额:
$ 80.79万 - 项目类别:
相似海外基金
Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
- 批准号:
BB/Y003756/1 - 财政年份:2024
- 资助金额:
$ 80.79万 - 项目类别:
Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
- 批准号:
MR/Y503435/1 - 财政年份:2024
- 资助金额:
$ 80.79万 - 项目类别:
Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
- 批准号:
10561406 - 财政年份:2023
- 资助金额:
$ 80.79万 - 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
- 批准号:
22KJ1113 - 财政年份:2023
- 资助金额:
$ 80.79万 - 项目类别:
Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
- 批准号:
BB/X001504/1 - 财政年份:2023
- 资助金额:
$ 80.79万 - 项目类别:
Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
- 批准号:
10584620 - 财政年份:2022
- 资助金额:
$ 80.79万 - 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
- 批准号:
576016-2022 - 财政年份:2022
- 资助金额:
$ 80.79万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
- 批准号:
10657417 - 财政年份:2022
- 资助金额:
$ 80.79万 - 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
- 批准号:
10389517 - 财政年份:2022
- 资助金额:
$ 80.79万 - 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
- 批准号:
RGPIN-2019-07122 - 财政年份:2022
- 资助金额:
$ 80.79万 - 项目类别:
Discovery Grants Program - Individual